Petros Pharmaceuticals, Inc. (PTPI) Net income 2020–2025
Petros Pharmaceuticals, Inc. (PTPI) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$1.9MFY2025 · since FY2020: -$20.6M → $1.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.9M | +113.4% |
| FY2024 | -$14.3M | -75.4% |
| FY2023 | -$8.2M | +59.3% |
| FY2022 | -$20.0M | -123.0% |
| FY2021 | -$9.0M | +56.3% |
| FY2020 | -$20.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice